HNGE Hinge Health, Inc.
USHealthcareAs of 2026-07-10 16:00
Why HNGE matters now
Hinge Health, Inc. (HNGE) is a US stock in Healthcare. The latest InvestLog snapshot shows $88.80 with -1.25% on the session and $6.87B in market capitalization; recent performance reads 1-month +26.31% and YTD +49.45%.
The latest financial table shown here is Q1 2026, with revenue of $182.3M, net income of $35.1M, and EPS of $0.41. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 3.8%.
InvestLog's latest related AI research is a Signal Cluster note titled "HNGE signal cluster: 3 Form 144 planned-sale filing signals in seven days". The latest indexable market news headline is "Hinge Health to announce second quarter 2026 financial results on August 4, 2026" from Business Wire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $76.00; recent insider activity includes Insight Holdings Group, LLC filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
17.52
P/S
8.31
EV/EBITDA
-9.96
DCF Value
$-137.75
FCF Yield
3.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
80.8%
Operating Margin
-81.6%
Net Margin
-78.9%
ROE
-138.7%
ROA
-70.0%
ROIC
-165.6%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $182.3M | $35.1M | $0.41 |
| Q4 2025 | $170.7M | $32.1M | $0.37 |
| FY 2025 | $587.9M | $-528.3M | $-5.19 |
| Q3 2025 | $154.2M | $-1.8M | $-0.02 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$75.33
Target (Median)
$76.00
Target Range
$45.00 - $95.00
Trading Activity
Insider Trades
Related AI Research
HNGE signal cluster: 3 Form 144 planned-sale filing signals in seven daysHNGE 7日信号聚集：3 条 Form 144 计划减持 信号
On June 29, 2026, ticker HNGE recorded a 7-day signal window (June 22–June 29, 2026) with 3 total signals, all categorized as Form 144 Sale filings.2026年6月29日，股票代码HNGE在7天（2026年6月22日至6月29日）窗口期内出现3笔信号，全部归类为Form 144出售申报，且所有申报均于当日提交，申报优先级介于77至100之间。Form 144是美国SEC要求内幕人士及关联方披露股份出售计划的法定备案文件，集中提交的申报意味着多名关联方已公开披露减持计划，将增加二级市场流通盘供给，可能带来短期市场流动性压力。
HNGE signal cluster: 3 insider and analyst signals in seven daysHNGE 7日信号聚类：3 条内部人/分析师信号
On June 16, 2026, a 7-day trading window for ticker HNGE (Hinge Health, Inc.) contained a cluster of 3 identical insider trading signals, all categorized as Form 144 Sale filings.2026年6月16日，股票代码HNGE（Hinge Health, Inc.）的7天交易窗口期内出现3笔同标的内幕交易集群信号，全部为Form 144出售申报。本次集群包含3笔优先级分别为100、82、77的Form 144出售申报，均在同一交易日提交，属于集中性的内幕股份出售预告信号，值得市场参与者关注。
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
US
Exchange
—
Beta
1.99
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.